Advertisement

Clinical Relevance of Immune Complexes, Associated Antigen, and Antibody in Cancer

  • Fernando A. Salinas
  • Kian H. Wee
  • Hulbert K. Silver
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 15)

Abstract

During the past 15 years there has been an increased interest in tumor-associated antigens (TAA) and the potential clinical role their immunologically oriented markers may play in the management of human cancer. One such immunological test for human tumor-associated markers, the identification of circulating immune complexes (CIC), is the subject of this volume.

Keywords

Systemic Lupus Erythematosus Immune Complex Tumor Burden Human Melanoma Cell Line Culating Immune Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aarden, L.A., 1977, Pathogenesis of immune complexes, in: Non-articular Forms of Rheumatoid Arthritis ( T.A.N. Feltkamp, ed.), pp. 15–36, Stafleu, Leiden.Google Scholar
  2. Abrass, C.K., Nies, K.M., Louie, J.S., Border, W.A., and Glassock, R.J., 1980, Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus, Arthritis Rheum. 23: 273.PubMedGoogle Scholar
  3. Agnello, V., 1981, Immune complex assays: The first ten years (editorial), Ann. Int. Med. 94: 266.PubMedGoogle Scholar
  4. Amlot, P.L., Pussel, D., Slaney, J.M., and Williams, B.D., 1978, Correlation between immune complexes and prognostic factors in Hodgkin’s disease, Clin. Exp. Immunol. 31: 166.PubMedGoogle Scholar
  5. Andrews, B.S., Mcintosh, J., Petts, V., and Penny, R., 1977, Circulating immune complexes in retinal vasculitis, Clin. Exp. Immunol 29: 23.PubMedGoogle Scholar
  6. Atkins, C.J., Kondon, J.J., Quismorio, F.P., and Friou, G.J., 1972, The choroid plexus in systemic lupus erythematosus, Ann. Int. Med. 76: 65.PubMedGoogle Scholar
  7. Baldwin, R.W., and Robins, R.A., 1980, Circulating immune complexes in cancer, in: Cancer Markers ( S. Sell, ed.), pp. 507–531, Humana Press, Clifton, New Jersey.Google Scholar
  8. Bansal, S.C., Bansal, B.R., Thomas, H.L., Siegel, P.D., Rhoads, J.E., Cooper, D.R., Terman, D.S., and Mark, R., 1978, Ex vivo removal of serum IgG in a patient with colon carcinoma, Cancer 42: 1.PubMedGoogle Scholar
  9. Barnett, E.V., Knutson, D.W., Abrass, C.K., Chia, D.S., Young, L.S., and Liebling, M.R., 1979, Circulating immune complexes: Their immunohistochemistry, detection and importance, Ann. Intern. Med. 91: 430.Google Scholar
  10. Benacerraf, B., Sebestyen, M., and Cooper, N.S., 1959, The clearance of antigen-antibody complexes from the blood by the reticuloendothelial system, J. Immunol 82: 131.PubMedGoogle Scholar
  11. Bensinger, W.I., Kinet, J.B., Hennen, G., Franckenne, F., Schaus, C., Saint-Remy, M., Hoyoux, P., and Mahieu, P., 1982, Plasma perfused over immobilized protein A for breast cancer, N. Engl. J. Med. 306: 935.Google Scholar
  12. Bertram, J.H., Hengst, C.D., and Mitchell, M.S., 1984, Staphylococcal protein A immuno- adsorptive column induces mitogenicity in perfused plasma, J. Biol. Resp. Modif. 3: 235.Google Scholar
  13. Berzofsky, J.A., and Berkower, I.J., 1984, Antigen-antibody interaction, in: Fundamental Immunology ( W.E. Paul, ed.), pp. 595–644, Raven Press, New York.Google Scholar
  14. Bhattacharya, M., Chatterjee, S.K., Barlow, J.J., and Fuji, H., 1982, Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas, Cancer Res. 42: 1650.PubMedGoogle Scholar
  15. Brandeis, W.E., Welson, L., Wang, Y., Good, R.A., and Day, N.K., 1978, Circulating immune complexes in sera of children with neuroblastoma, Clin. Invest. 62: 1201.Google Scholar
  16. Brennan, F.M., Grace, S.A., and Elson, C.J., 1983, Preparation of covalent IgG complexes of defined size and their clearance from the circulation of mice, J. Immunol. Methods 56: 149.PubMedGoogle Scholar
  17. Brown, T.S., Russel, M.W., and Mestecky, J., 1982, Hepatobiliary transport of IgA immune complexes: Molecular and cellular aspects, J. Immunol. 128: 2183.PubMedGoogle Scholar
  18. Cairns, S.A., London, A., and Mallick, N.P., 1980, The value of three immune complex assays in the management of systemic lupus erythematosus: An assessment of immune complex level, size and immunochemical properties in relation to disease activity and manifestations, Clin. Exp. Immunol. 40: 273.PubMedGoogle Scholar
  19. Carpentier, N.A., and Miescher, P.A., 1983, The clinical relevance of circulating immune complexes in cancer, kidney transplantation and pregnancy, in: Immunobiology of Transplantation, Cancer and Pregnancy ( P.K. Ray, ed.), pp. 375–408, Pergamon Press, New York.Google Scholar
  20. Casali, P., and Lambert, P.H., 1979, Purification of soluble immune complexes using polymethylmethacrylate beads coated with conglutinin or Clq, Clin. Exp. Immunol. 37: 295.PubMedGoogle Scholar
  21. Catropia, J.P., Gutterman, J.V., Hersh, E.M., Granatek, C.H., and Mavligit, G.M., 1976, Antigen expression and cell surface properties of human leukemia blasts, Ann. N.Y. Acad. Sci 276: 146.Google Scholar
  22. Ceriani, R.L., Sasaki, M., Sussman, H., Wara, W.M., and Blank, E.W., 1982, Circulating human mammary epithelial antigens in breast cancer, Proc. Natl. Acad. Sci. USA 79: 5420.PubMedGoogle Scholar
  23. Chee, D.O., Gupta, R.B., and Morton, D.L., 1983, Humoral response of melanoma patients to two different tumor-associated antigens, J. Surg. Oncol. 23: 228.PubMedGoogle Scholar
  24. Chia, D., Barnett, E.V., Yamagata, J., Knutson, D., Restivo, C., and Furst, D., 1979, Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG), Clin. Exp. Immunol. 60: 399.Google Scholar
  25. Chu, T.M., Maidment, B.M., Koestler, T.P., Papsidero, L.D., Inaji, H., Creghan, G., Killian, C.S., Loor, R.M., Douglas, H.O., Berjian, R., and Nemoto, T., 1983, Immune complexes and cancer, in: Immunodiagnosis ( R. Alosi and J. Hyun, eds.), pp. 259–268, Alan R. Liss, New York.Google Scholar
  26. Cochrane, C.G., and Koffler, D., 1973, Immune complex disease in experimental animals and man, Adv. Immunol. 16: 185.PubMedGoogle Scholar
  27. Cochrane, C.G., and Weigle, W.O., 1958, The cutaneous reaction to soluble antigen-antibody complexes: A comparison with the Arthus phenomenon, J. Exp. Med. 108: 591.PubMedGoogle Scholar
  28. Crane, M.M., Rossen, R.D., McCredie, K.B., and Trujillo, J.M., 1984, Association of circulating immune complexes with cytogenetic abnormalities but not with prognosis in acute nonlymphocytic leukemia, Cancer Res. 44: 3125.PubMedGoogle Scholar
  29. Cronin, W.J., Dorsett, B.H., and Ioachim, H.L., 1982, Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera, Cancer Res. 42: 292.PubMedGoogle Scholar
  30. Cupps, T.R., and Fauci, A.S., 1982, Neoplasm and systemic vasculitis: A case report, Arthritis Rheum. 25: 475.PubMedGoogle Scholar
  31. Currie, A., 1973, Circulating antigen as inhibitor of tumor immunity in man, Br. J. Cancer (Suppl. 1 ) 28: 153.Google Scholar
  32. Dahlgren, C., and Elwing, H., 1983, Inhibition of polymorphonuclear leukocyte locomotion by surface bound antigen-antibody complex, Immunology 49: 329.PubMedGoogle Scholar
  33. D’Amelio, R., Brighouse, G., Barnet, M., and Lambert, P.H., 1981, Antigen-specific detection of soluble immune complexes in conglutinin binding assays, Clin. Exp. Immunol. 45: 283.PubMedGoogle Scholar
  34. Day, N.K., Winfield, J.B., Gee, T., Winchester, R.J., Teshima, H., and Kunkel, H.G., 1976, Evidence for immune complexes involved in antilymphocyte antibodies associated with hypocomplementemia in chronic lymphocytic leukemia (CLL), Clin. Exp. Immunol. 26: 189.PubMedGoogle Scholar
  35. Delire, M., Cambiaso, C.L., and Masson, P.L., 1978, Circulating immune complexes in infants fed on cow’s milk, Nature 272: 632.PubMedGoogle Scholar
  36. Dennert, G., 1971, The mechanism of antibody-induced stimulation and inhibition of the immune response, J. Immunol. 106: 951.PubMedGoogle Scholar
  37. De Swiet, J., and Wells, A.L., 1957, Nephrotic syndrome associated with renal venous thrombosis and bronchial carcinoma, Br. Med. J. 5031: 1341.Google Scholar
  38. Diener, E., and Feldman, M., 1970, Antibody-mediated suppression of the immune response in vitro. II. A new approach to the phenomenon of immunological tolerance, J. Exp. Med. 132: 31.PubMedGoogle Scholar
  39. Dixon, F.J., Vasquez, J.J., Weigle, W.O., and Cochrane, C.G., 1958, Pathogenesis of serum sickness, Arch. Pathol. 65: 18.Google Scholar
  40. Dixon, F.J., Feldman, J.D., and Vasquez, J.J., 1961, Experimental glomerulonephritis, J. Exp. Med. 113: 899.PubMedGoogle Scholar
  41. Dorval, G., and Pross, H., 1983, Immune complexes in cancer, in: Circulating Immune Complexe ( L. Espinoza and C. Osterland, eds.), pp. 161–171, Futura, New York.Google Scholar
  42. Eagan, J.W., Roberts, J.L., Schwartz, M.M., and Lewis, E.J., 1979, The composition of pulmonary immune deposits in systemic lupus erythematosus, Clin. Immunol. Immunopathol. 12: 204.Google Scholar
  43. Fauci, A.S., 1981, The revolution in clinical immunology, J. Am. Med. Assoc. 246: 2567.Google Scholar
  44. Feldman, M., and Diener, E., 1970, Antibody-mediated suppression of the immune response in vitro, J. Exp. Med. 131: 247.Google Scholar
  45. Feldman, M., and Diener, E., 1972, Antibody mediated suppression of the immune response in vitro. IV. The effect of antibody fragments, J. Immunol. 108: 93.Google Scholar
  46. Fer, M.F., Beman, J., Stevenson, H.C., Maluish, A., Moratz, C., Delawter, T., Foon, K., Herberman, R.B., Oldham, R.K., Terman, D.S., Young, J.B., and Daskal, Y., 1984, A trial of autologous plasma perfusion over protein A in patients with breast cancer, J. Biol. Resp. Modif. 3: 352.Google Scholar
  47. Finbloom, D.S., Abeles, D., Rifai, A., and Plotz, P.H., 1980, The specificity of uptake of model immune complexes and other protein aggregates by the murine reticuloendothelial system, J. Immunol 125: 1060.PubMedGoogle Scholar
  48. Forsgren, A., and Sjoquist, J., 1966, Protein A from Staphylococcus aureus. I. Pseudo immune reaction with human globulin, J. Immunol. 97: 822.PubMedGoogle Scholar
  49. Friou, G.J., 1974, Current knowledge and concepts of the relationship of malignancy, autoimmunity and immunologic disease, Ann. N.Y. Acad. Sci. 230: 23.PubMedGoogle Scholar
  50. Frost, P., and Kerbel, R.S., 1983, Immunology of metastasis.Can the immune response cope with disseminated tumor? Cancer Metastasis Reviews 2: 239.PubMedGoogle Scholar
  51. Fust, G., Fekete, B., Angyal, I., Jakab, A., Pal, A., Meretey, K., Falus, A., Torok, K., Szegedi, GY., Kavai, M., Puskas, E., Cseci-Nagy, M., Szabo, T., Lenkey, A., and Misz, M., 1981, Evaluation of different methods for detecting circulating immune complexes: Studies in patients with lung cancer, J. Immunol Methods 46: 259.PubMedGoogle Scholar
  52. Gauci, L., Caraux, J., and Serrou, B., 1981, Immune complexes in the context of the immune response in cancer patients, in: Immune Complexes and Plasma Exchanges in Cancer Patients ( B. Serrou and C. Rosenfeld, eds.), pp. 37–98, Elsevier/North-Holland, Amsterdam.Google Scholar
  53. Gauthier, V.J., Mannik, M., and Striker, G.E., 1982, Effect of cationized antibodies in preformed immune complexes on deposition and persistence in renal glomeruli, J. Exp. Med. 156: 766.PubMedGoogle Scholar
  54. Germuth, F.G., Jr., and Rodriguez, E., 1973, Immunopathology of the Renal Glomerulus, Little, Brown, Boston.Google Scholar
  55. Germuth, F.G., Jr., Flanagan, C., and Montenegro, M.R., 1957, The relationship between the chemical nature of the antigen, antigen dosage rate of antibody synthesis and the occurrence of arteritis and glomerulonephritis in experimental hypersensitivity, Johns Hopkins Med. J. 101: 149.Google Scholar
  56. Gilead, Z., Troy, F.A., and Sulitzeanu, D., 1981, Isolation and electrophoretic analysis of immune complexes from patients with breast cancer, Eur. J. Cancer Clin. Oncol. 17: 1165.PubMedGoogle Scholar
  57. Giuliano, A.E., Rangel, D., Golub, S.H., Holmes, E.C., and Morton, D.L., 1979, Serum- mediated immunosuppression in lung cancer, Cancer 43: 917.PubMedGoogle Scholar
  58. Gleicher, N., and Siegel, I., 1981, Common denominators of pregnancy and malignancy, in: Reproductive Immunology ( N. Gleicher, ed.), pp. 339–353, Alan R. Liss, New York.Google Scholar
  59. Gordon, B.R., Moroff, S., Hurvitz, A.I., Matus, R.E., MacEwen, E.G., Good, R.A., and Day, N.K., 1980, Circulating immune complexes in sera of dogs with benign and malignant breast disease, Cancer Res. 40: 3627.PubMedGoogle Scholar
  60. Grace, S.A., and Brennan, F.M., 1982, Clearance and localization of immunoglobulin oligomers in mice with chronic circulating endogenous complexes, Immunology 47: 221.PubMedGoogle Scholar
  61. Grandeis, W.E., Tan, C., Yang, Y., Good, R.A., and Day, N.K., 1980, Circulating immune complexes, complement and complement component levels in childhood Hodgkin’s disease, Clin. Exp. Immunol. 39: 551.Google Scholar
  62. Greenberg, E., Divertie, M.B., and Woolner, L.B., 1964, A review of unusual systemic manifestations associated with carcinoma, Am. J. Med. 36: 106.PubMedGoogle Scholar
  63. Gupta, R.K., and Morton, D.L., 1981, Possible clinical significance of circulating immune complexes in melanoma patients, in: Fundamental Mechanisms in Human Cancer Immunology ( J.P. Sanders, J. Daniels, B. Serrou, D. Rosenfeld, and C. Denney, eds.), pp. 305–320, Elsevier/North Holland, Amsterdam.Google Scholar
  64. Gupta, R.K., and Morton, D.L., 1983, Immunochemical characterization of fetal antigen isolated from spent culture medium of a human melanoma cell line, J. Natl. Cancer Inst. 70: 993.PubMedGoogle Scholar
  65. Gupta, R.K., and Morton, D.L., 1984a, Studies of a melanoma tumor-associated antigen detected in spent culture medium of a human melanoma cell line by allogeneic antibody. I. Purification and development of a radioimmunoassay, J. Natl. Cancer Inst. 72: 67.PubMedGoogle Scholar
  66. Gupta, R.K., and Morton, D.L., 1984b, Studies of a melanoma tumor-associated antigen detected in spent culture medium of a human melanoma cell line by allogeneic antibody. II. Immunobiological characterization, J.Natl Cancer Inst. 72: 75.PubMedGoogle Scholar
  67. Gupta, R.K., and Morton, D.L., 1984c, Studies of a melanoma tumor-associated antigen detected in spent culture medium of a human melanoma cell line by allogeneic antibody. III. Physicochemical properties, J. Natl Cancer Inst. 72: 83.PubMedGoogle Scholar
  68. Gupta, R.K., Golub, S.H., and Morton, D.L., 1979, Correlation between tumor burden and anticomplementary activity in sera from cancer patients, Cancer Immunol Immunother. 6: 63.Google Scholar
  69. Gupta, R.K., Leitch, A.M., and Morton, D.L., 1983a, Detection of tumor-associated antigen in eluates from protein-A columns used for ex-vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay, Clin. Exp. Immunol 53: 589.PubMedGoogle Scholar
  70. Gupta, R.K., Leitch, A.M., and Morton, 1983b, Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients, Cancer Immunol Immunother. 16: 40.PubMedGoogle Scholar
  71. Haakenstad, A.O., and Mannik, M., 1974, Saturation of the reticuloendothelial system with soluble immune complexes, J. Immunol 112: 1939.PubMedGoogle Scholar
  72. Haakenstad, A.O., and Mannik, M., 1977, The biology of immune complexes, in: Autoimmunity ( N. Talal, ed.), pp. 277–360, Academic Press, New York.Google Scholar
  73. Halpern, B., 1974, Role of the reticuloendothelial system in the clearance of macromolecules, in: Enzyme Therapy in Lysosomal Storage Disease ( J.M. Tager, G.J.M. Hooghwinkel, and Th.W. Daems, eds.), pp. 111–123, North Holland, Amsterdam.Google Scholar
  74. Hartmann, D.P., 1975, The identification and role of anti-immunoglobulin in human malignancy, Ph. D. thesis, McGill University, Montreal, Canada.Google Scholar
  75. Hay, F.C., Lynn, J., Roitt, N., and Roitt, I.M., 1976, Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase Clq, Clin. Exp. Immunol 24: 396.PubMedGoogle Scholar
  76. Heier, H.E., Carpentier, N., Lange, G., Lambert, P.H., and Godal, T., 1977, Circulating immune complexes in patients with malignant lymphoma and solid tumors, Int. J. Cancer 20: 887.PubMedGoogle Scholar
  77. Heimer, R., and Per, S., 1982, Pitfalls in the methodology for detection of immune complexes, Surv. Immunol Res. 1: 109.PubMedGoogle Scholar
  78. Hellstrom, K.E., and Hellstrom, I., 1974, Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigen, Adv. Immunol 18: 209.PubMedGoogle Scholar
  79. Hendrick, J.C., Zangerle, P.F., Franchimonk, P., Samak, R., and Israel, L., 1981, Isolation of immune complexes from cancerous patients and antigen characterization, in: Immune Complexes and Plasma Exchanges in Cancer Patients ( B. Serrou and G.C. Rosenfeld, eds.), pp. 29–36, Elsevier/North-Holland, Amsterdam.Google Scholar
  80. Herberman, R.B., 1982, Immunological approach to the biochemical markers for cancer, in: Biochemical Markers for Cancer ( T. Ming Chu, ed.), pp. 1–23, Marcel Dekker, New York.Google Scholar
  81. Herberman, R.B., Bordes, M., Lambert, P.H., Luthra, H.S., Robins, R.A., Sizaret, P., and Theofilopoulos, A., 1981, Report on international comparative evaluation of possible value of assays for immune complexes for diagnosis of human breast cancer, Int. J. Cancer 27: 569.PubMedGoogle Scholar
  82. Hersey, P., Edward, A., Adams, E., Ibister, J.P. Murrey, E., Biggs, J.C., and Milton, S.W., 1976, Antibody-dependent cell-mediated cytotoxicity against melanoma cells induced by plasmapheresis, Lancet 1: 825.PubMedGoogle Scholar
  83. Higgens, M.R., Randall, R.E., and Still, W.J.S., 1974, Nephrotic syndrome with oat-cell carcinoma, Br. Med. J. 3: 450.Google Scholar
  84. Hoffken, K., Meredith, I.D., Robins, R.A., Baldwin, R.W., Davis, C.J., and Blamery, R.W., 1977, Circulating immune complexes in patients with breast cancer, Br. Med. J. 2: 218.PubMedGoogle Scholar
  85. Holdsworth, S.R., Neale, T.J., and Wilson, C.B., 1980, The participation of macrophages and monocytes in experimental immune complex glomerulonephritis, Clin. Immunol Immunopathol. 15: 510.PubMedGoogle Scholar
  86. Holohan, T.V., Philips, T.M., Bowles, C., and Deisseroth, A., 1982, Regression of canine mammary carcinoma after immunoadsorption therapy, Cancer Res. 42: 3663.PubMedGoogle Scholar
  87. Horvath, M., Fekete, B., and Rahoty, P., 1982, Investigation of circulating immune complexes in patients with breast cancer, Oncology 39: 20.PubMedGoogle Scholar
  88. Houghton, A.N., Brooks, H., Cote, P.J., Taormina, M.C., Oettgen, H.F., and Old, L.J., 1983, Detection of cell surface and intracellular antigens by human monoclonal antibodies: Hybrid cell lines derived from lymphocytes of patients with malignant melanoma, J. Exp. Med. 158: 53.PubMedGoogle Scholar
  89. Houston, W.E., Pedersen, C.E., Jr., Cole, F.E., Jr., and Spertzel, R.O., 1974, Effects of antigen-antibody complexes in the primary immune response in Rhesus monkeys, Infect. Immun. 10: 437.PubMedGoogle Scholar
  90. Isbister, W.H., Noonan, F.P., Halliday, W.J., and Clunie, G., 1975, Human thoracic duct cannulation: Manipulation of tumor-specific blocking factors in a patient with malignant melanoma, Cancer 35: 1465.PubMedGoogle Scholar
  91. Israel, L., Edelstein, R., Mannoni, P., Rodot, E., and Greenspan, E.M., 1977, Plasmapheresis in patients with disseminated cancer: Clinical results and correlations with changes in serum protein. The concept of nonspecific blocking factors, Cancer 40: 3146.PubMedGoogle Scholar
  92. Issekutz, A.C., and Bhimji, S., 1982, Effect of nonsteroid anti-inflammatory agents on immune complex and chemotactic factor-induced inflammation, Immunopharmacology 4: 253.PubMedGoogle Scholar
  93. Jaffers, G.J., Colvin, R.B., Cosini, A.B., Giorgi, J.V., Goldstein, G., Fuller, T.C., Kurnick, J.T., Lillehie, C., and Russell, P.S., 1983, Immunological monitoring of diabetic and nondiabetic recipients of renal allografts, Transplant. Proc. 15: 646.Google Scholar
  94. Jones, F.R., Yoshida, L.H., Ladiges, W.C., and Kennedy, M.A., 1980, Treatment of feline leukemia and reversal of FeLV by ex vivo removal of IgG: A preliminary report, Cancer 46: 675.PubMedGoogle Scholar
  95. Jones, V.E., and Orlans, E., 1981, Isolation of immune complexes and characterization of their constituent antigens and antibodies in some human diseases: A review, J. Immunol. Methods 44: 249.PubMedGoogle Scholar
  96. Kabat, E.A., 1980, Basic principles of antigen-antibody reactions, Methods Enzymol. 70A: 3.PubMedGoogle Scholar
  97. Kaplan, A.P., 1981, Immune complexes and connective tissue disease, Bull. N.Y. Acad. Med. 57: 638.PubMedGoogle Scholar
  98. Kessler, S.W., 1975, Rapid isolation of antigen from cells with a staphylococcal protein A antibody adsorbent: Parameters of the interaction of antibody-antigen complexes, J. Immunol. 115: 1617.PubMedGoogle Scholar
  99. Kilgallon, W., Amlot, P.L., and Williams, B.D., 1983, Immune complexes in Hodgkin’s disease: Isolation, immunochemical and physiochemical analysis, Clin. Exp. Immunol. 53: 308.PubMedGoogle Scholar
  100. Knutson, D.W., Kylstra, A., and Van Es, L.A., 1977, Association and dissociation of aggregated IgA from rat peritoneal macrophases, J. Exp. Med. 145: 1368.PubMedGoogle Scholar
  101. Koprowski, H., Herlyn, D., Lubeck, M., DeFreitas, E., and Sears, H.F., 1984, Human antiidiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient? Proc. Natl Acad. Sci. USA 81: 216.PubMedGoogle Scholar
  102. Korec, S., Smith, F.P., Schein, P.S., and Phillips, T.M., 1984, Clinical experiences with extracorporeal immunoperfusion of plasma from cancer patients, J. Biol Resp.Modif. 3: 330.Google Scholar
  103. Krapf, F., Renger, D., Schedel, I., Fricke, M., Kemper, A., and Deicher, H., 1983, Circulating immune complexes in malignant diseases: Increased detection rate by simultaneous use of three assay methods, Cancer Immunol. Immunother. 15: 138.PubMedGoogle Scholar
  104. Kristensen, E., Brandslund, I., Nielsen, H., and Svehag, S.E., 1980, Prognostic value of assays for circulating immune complexes and natural cytotoxicity in malignant skin melanoma (stages I and II), Cancer Immunol. Immunother. 9: 31.Google Scholar
  105. Lachmann, P.J., Macanovic, M., Harkiss, G.D., Oldroyd, R.G., and Habicht, J., 1981, The isolation of the antibody moieties of immune complexes from serum by the pepsin digestion of conglutinin-anti-conglutinin complexes, Clin. Exp. Immunol. 46: 250.PubMedGoogle Scholar
  106. Lahey, S.J., Steele, G., Jr., Rodrick, M.L., Berkowitz, R., Goldstein, D.P., Ross, D.S., Ravikumar, T.S., Wilson, R.E., Byrn, R., Thomas, P., and Zamcheck, N., 1984, Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia, Cancer 53: 1316.PubMedGoogle Scholar
  107. Laissue, J., Cottier, H., Hess, M.W., and Stoner, R.D., 1971, Early and enhanced germinal centre formation and antibody responses in mice after primary stimulation with antigen-isologous antibody complexes as compared with antigen alone, J. Immunol 107: 822.PubMedGoogle Scholar
  108. Lambert, P.H., Dixon, F.J., Zubler, R.H., Agnello, V., Cambiaso, C., Casali, P., Clarke, J., Cowdery, J.S., McDuffie, F.C., Hay, F.C., MacLennan, I.C.M., Masson, P., Muller- Eberhard, H.J., Penttinen, K., Smith, M., Tappeiner, G., Theofilopoulos, A.N., and Verroust, P., 1978, A WHO collaborative study for the evaluation of eighteen methods for detecting immune complexes in serum, J. Clin. Lab. Immunol. 1: 1.Google Scholar
  109. Lamers, M.C., 1981, Factors influencing the development of immune complex diseases, Allergy 36: 527.PubMedGoogle Scholar
  110. Lamers, M.C., DeGroot, E.R., and Roos, D., 1981, Phagocytosis and degradation of DNA- anti-DNA complexes by human phagocytes. I. Assays, conditions, quantitative aspects and differences between human blood monocytes and neutrophils, Eur. J. Immunol 11: 757.PubMedGoogle Scholar
  111. Langone, J.J., Das, C., Bennett, D., and Terman, D.S., 1984, Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer, J. Immunol 133(2): 105 7.Google Scholar
  112. Lee, J.C., Yamauchi, H., and Hopper, J., 1966, The association of cancer and the nephrotic syndrome, Ann. Intern. Med. 64: 41.PubMedGoogle Scholar
  113. Leslie, R.G.Q., 1980, Macrophage handling of soluble immune complexes: Use of specific inhibitors to study the biochemical events involved in complex catabolism, Eur. J. Immunol 10: 799.PubMedGoogle Scholar
  114. Lewis, M.G., and Pelgrum, G.D., 1978, Autoimmune antibodies in chronic lymphatic leukemia, Br. J. Haematol 38: 75.PubMedGoogle Scholar
  115. Lewis, M.G., Loughridge, L.W., and Phillips, T.M., 1971, Immunological studies on a patient with the nephrotic syndrome associated with malignancy of non-renal origin, Lancet 2: 134.PubMedGoogle Scholar
  116. Lightfoot, R.W., Drusin, R.E., and Christian, C.L., 1970, Properties of soluble immune complexes, J. Immunol 105: 1493.PubMedGoogle Scholar
  117. Longscope, W.T., and Rackemann, F.M., 1918, The relation of circulating antibodies to serum disease, J. Exp. Med. 27: 341.Google Scholar
  118. Lookwood, C.M., Worlledge, S., Nicholas, A., Cotton, C., and Peters, D.K., 1979, Reversal of impaired splenic function by plasma exchange, N. Engl J. Med 300: 524.Google Scholar
  119. McCormick, J.R., Harkin, M.M., Johnson, K.J., and Ward, P.A., 1981, Suppression of superoxide dismutase of immune-complex-induced pulmonary alveolitis and dermal inflammation, Am. J. Pathol 102: 55.PubMedGoogle Scholar
  120. MacKintosh, F.R., Bennet, K., Schiff, S., and Hall, S.W., 1983, Treatment of advanced malignancy with plasma perfused over staphylococcal protein A, West. J. Med. 139: 36.PubMedGoogle Scholar
  121. Maidment, B.W., Papsidero, L.D., Nemoto, T., and Chu, T.M., 1981, Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing, Cancer Res. 41: 795.PubMedGoogle Scholar
  122. Male, D., and Roitt, I.M., 1979, Analysis of the components of immune complexes, J. Mol. Immunol 16: 197.Google Scholar
  123. Mannik, M., and Arend, W.P., 1971, Fate of preformed immune complexes in rabbits and rhesus monkeys, J. Exp. Med. 134: 195.Google Scholar
  124. Masserschmidt, G., Bowles, C., Dean, D., Parker, M., Lester, R., Dowling, R., Holohan,T., Osborn, L., Schaff, B.F., McCormack, K., Corbitt, R., Phillips, T., Glasstein, E., and Diesseroth, A., 1982, Phase II trial of S. aureus Cowan I immunoperfusion, Cancer Treat. Rep. 66: 2027.Google Scholar
  125. Masson, P., 1978, Are circulating immune complexes the key to immunopathology? in: Protides of the Biological Fluids ( H. Peeters, ed.), Vol. 25, pp. 3–7, Pergamon Press, New York.Google Scholar
  126. Morgan, A.C., and Mclntyre, R.F., 1983, Monoclonal antibodies to human melanoma-associated antigens: An amplified enzyme-linked immunoadsorbent assay for the detection of antigen, antibody and immune complexes, Cancer Res. 43: 3155–3159.PubMedGoogle Scholar
  127. Morgan, A.C., Jr., Crane, M.M., and Rossen, R.D., 1984, Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: Correlation of circulating antigen levels with tumor burden, J. Natl. Cancer Inst. 72: 243.PubMedGoogle Scholar
  128. Ninnemann, J.L., 1981, Tumor associated immunosuppressive serum proteins, in: The Handbook of Cancer Immunology ( H. Waters, ed.), pp. 376–406, Garland STPM Press, New York.Google Scholar
  129. Nydegger, U.E., Kazatchkine, M.D., Lambert, P.H., and Miescher, P.A., 1983, Immunopathology of immune complex disease, in: The Reticuloendothelial System: A Comprehensive Treatise, Vol.4: Immunopathology ( N.R. Rose and B.V. Siegel, eds.), pp. 371–390, Plenum Press, New York.Google Scholar
  130. Oldham, R.K., 1984, Introduction, J. Biol. Resp. Modif. 3: 229–230.Google Scholar
  131. Ozawa, T., Pluss, R., Lacher, J., Boedecker, E., Guggenheim, S., Hammond, W., and Mcintosh, R., 1971, Endogenous immune complex nephropathy associated with malignancy. I. Studies of the nature and immunopathogenic significance of glomerular bound antigen and antibody isolation and characterization of tumor specific antigen and antibody and circulating immune complexes, Q. J. Med. 44: 523.Google Scholar
  132. Paganelli, R., Levinsky, R.J., Brosstoff, J., and Wraith, D.G., 1979, Immune complexes containing food proteins in normal and atopic subjects after oral challenge and effect of sodium chromoglycate on antigen absorption, Lancet 1: 1270.PubMedGoogle Scholar
  133. Papsidero, L.D., Nemoto, T., Snyderman, M.C., and Chu, T.M., 1979, Immune complexes in breast cancer patients as detected by Clq binding, Cancer 44: 1636.PubMedGoogle Scholar
  134. Peeters, H. (ed.), 1979, Protides of the Biological Fluids, Vol. 26, Pergamon Press, London.Google Scholar
  135. Penn, I., 1981, Depressed immunity and the development of cancer, Clin. Exp. Immunol. 46: 459.PubMedGoogle Scholar
  136. Pereira, A.B., Theofilopoulos, A.N., and Dixon, F.J., 1980, Detection and partial characterization of circulating immune complexes with solid-phase anti-C3, J. Immunol. 1025: 763.Google Scholar
  137. Petrone, W.F., English, D.K., Wong, K., and McCord, J.M., 1981, Free radicals and inflammation: The superoxide dependent activation of a neutrophil chemotactic factor in plasma, Proc. Natl. Acad. Sci. USA 77: 1159.Google Scholar
  138. Phillips, T.M., MacDonald, J.S., and Lewis, M.G., 1981, Towards tumour antibody isolation and characterization in immune complexes, in: Immune Complexes and Plasma Exchanges in Cancer Patients ( B. Serrou and C. Rosenfeld, eds.), pp. 3–28, Elsevier/North-Holland, Amsterdam.Google Scholar
  139. Phillips, T.M., Queen, W.D., and Lewis, M.G., 1982, The significance of circulating immune complexes in patients with malignant melanoma, in: Melanoma Antigens and Antibodies ( R.A. Reisfeld and S. Ferrone, eds.), pp. 289–316, Plenum Press, New York.Google Scholar
  140. Pincus, T., Haberkern, R., and Christian, C.L., 1968, Experimental chronic glomerulitis, J. Exp. Med. 127: 819.PubMedGoogle Scholar
  141. Poskitt, P.K., and Poskitt, T.R., 1979, The LI210 assay for immune complexes: Application in cancer patients and correlation with disease progress, Int. J. Cancer 24: 560.PubMedGoogle Scholar
  142. Poulton, T.A., Crowther, M.E., Hay, F.C., and Nineham, L.J., 1978, Immune complexes in ovarian cancer, Lancet 2: 72.PubMedGoogle Scholar
  143. Poulton, T.A., Mooney, N.A., Nineham, L.J., and Hay, F.C., 1983, Characteristics of immune complexes detectable by two independent assays in gynaecological malignancies, Clin. Exp. Immunol. 53: 573.PubMedGoogle Scholar
  144. Price, M.R., and Baldwin, R.W., 1977, Shedding of tumor cell surface antigens, in: Dynamic Aspects of Cell Surface Organization ( G. Poste and G. Nicolson, eds.), pp. 423–471, Elsevier/North-Holland, New York.Google Scholar
  145. Puskas, E., Fust, G., Angyal, I., Phi, N.C., and Gergely, J., 1982, Serial measurement of circulating immune complexes in healthy subjects, Immunol. Lett. 4: 223.PubMedGoogle Scholar
  146. Quay, S.C., Murphy, G.F., and Mihm, M.C., Jr., 1983, Biochemical studies of immune complexes. II. Purification of immune complexes from sera of patients with malignant melanoma, Clin. Immunol. Immunopathol. 26: 318.PubMedGoogle Scholar
  147. Rabinovitch, M., Manejias, R.E., and Nussenzweig, V., 1975, Selective phagocytic paralysis induced by immobilized immune complexes, J. Exp. Med. 142: 827.PubMedGoogle Scholar
  148. Rajnavolgki, E., Fust, G., Kulics, J., Ember, J., Medgyesi, G.A., and Gergely, J., 1978, The effect of immune complex composition on complement activation and complement dependent complex disease, Immunochemistry 15: 887.Google Scholar
  149. Ray, P.K., McClaughlin, D., Mohammed, J., Idiculla, A., Rhoads, J.E., Jr., Mark, R., Bassett, J.G., and Cooper, D.R., 1981, Ex vivo immunoadsorption of IgG or its complexes-A new modality of cancer treatment, in: Immune Complexes and Plasma Exchanges in Cancer Patients ( B. Serrou and C. Rosenfeld, eds.), pp. 197–220, Elsevier/ North-Holland, Amsterdam.Google Scholar
  150. Ray, P.K., Idiculla, A., Mark, R., Rhoads, J.E., Jr., Thomas, H., Bassett, J.G., and Cooper, D.R., 1982, Extracorporeal immunoadsorption of plasma from a metastatic colon carcinoma patient by protein A-containing nonviable S. aureus, Cancer 49: 1800.PubMedGoogle Scholar
  151. Richmond, J., Sherman, R.S., Diamond, H.D., and Craver, L.F., 1962, Renal lesions associated with malignant lymphomas, Am. J. Med. 32: 184.PubMedGoogle Scholar
  152. Rifai, A., and Mannik, M., 1984, Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA, J. Immunol. 130: 1826.Google Scholar
  153. Rifai, A., Finbloom, D.S., Magilavy, D.B., and Plotz, P.H., 1982, Modulation of the circulation and hepatic uptake of immune complexes by carbohydrate recognition systems, J. Immunol. 128: 2269.PubMedGoogle Scholar
  154. Rose, L., and Lambert, P.H., 1980, The natural occurrence of circulating idiotype antiidiotype complexes during a secondary immune response to phosphorylcholine, Clin. Immunol. Immunopathol. 15: 481.PubMedGoogle Scholar
  155. Rossen, R.D., and Barnes, B.C., 1978, Measuring serum immune complexes in cancer (editorial), Ann. Int. Med. 88: 570.Google Scholar
  156. Rossen, R.D., and Morgan, A.C., 1981, Blockage of the humoral immune response: Immune complexes in cancer, in: The Handbook of Cancer Immunology, Vol. 9 ( H. Waters, ed.), pp. 209–280, Garland STPM Press, New York.Google Scholar
  157. Rossen, R.D., Reisberg, M.A., Hersh, E.M., and Gutterman, J.V., 1977, The Clq binding test for soluble immune complexes: Clinical correlations obtained in patients with cancer, Natl. Cancer Inst. 58: 1205.Google Scholar
  158. Rother, K., Rother, U., and Schindera, F., 1964, Passive Arthus-reaktion bei komplement-defekten Kanirchen, Z. Immun. Allergieforsch. 126: 473.Google Scholar
  159. Ruco, L.P., Procopio, A., Uccini, S., and Baroni, C.D., 1980, Increased monocyte phagocytosis in cancer patients, Eur.J. Cancer 16: 1315.PubMedGoogle Scholar
  160. Ruel, P., Murray, E., McCarthy, W.H., and Hersey, P., 1982, Evaluation of assays to detect immune complexes as an immunodiagnostic aid in patients with melanoma, Oncodev. Biol. Med. 3: 1.Google Scholar
  161. Salinas, F.A., and Wee, K.H., 1983, Immune complexes and human neoplasia. I., Biomed. Pharmacother. 36: 119.Google Scholar
  162. Salinas, F.A., Sheikh, K.H., and Chandor, S.B., 1978, Serological reactivity in cancer patients to human and mouse fetal liver cells, Cancer Res. 38: 401.PubMedGoogle Scholar
  163. Salinas, F.A., Silver, H.K.B., Weir, E.R., and Swenerton, K., 1980a, Circulating immune complexes (CIC) in ovarian carcinoma, Proc. Am. Soc. Clin. Oncol. 21: 162.Google Scholar
  164. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1980b, Detection and characterization of antibodies to xenogeneic oncofetal antigen (XOFA) in human neoplasia, in: Serologic Analysis of Human Cancer Antigens (S.A. Rosenberg, ed.), pp.539–568 and 665–667, Academic Press, New York.Google Scholar
  165. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1980c, Xenogenic oncofetal antigen (XOFA) and its relation with tumor burden in malignant melanoma (MM) patients, Proc. Am. Assoc. Cancer Res. 21: 225.Google Scholar
  166. Salinas, F.A., Silver, H.K.B., Grossman, L., and Thomas, J.W., 1981a, Plasmapheresis: A new approach in the management of advanced malignant melanoma, in: Immune Complexes and Plasma Exchanges in Cancer Patients ( B. Serrou and C. Rosenfeld, eds.), pp. 253–270, Elsevier/North-Holland. Amsterdam.Google Scholar
  167. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1981b, Immune complexes and human neoplasia: Detection and quantitation of circulating immune complexes by the fetal liver cell assay, Cancer Immunol. Immunother. 12: 11.Google Scholar
  168. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1981c, Malignant melanoma tumor burden and its relationship to antigen concentration, size and composition of circulating immune complexes, Proc. Am. Assoc. Cancer Res. 20: 181.Google Scholar
  169. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1981d, Modulation of lymphocyte activation by plasmapheresis in advanced malignant melanoma, in: Mechanisms of Lymphocyte Activation ( K. Resch, ed.), pp. 4790–4791, Elsevier/North-Holland, Amsterdam.Google Scholar
  170. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1982a, Xenogeneic oncofetal antigen (XOFA) immunoregulation in malignant melanoma, Proc. Int. Cancer Cong. 13: 309.Google Scholar
  171. Salinas, F.A., Wee, K.H., Silver, H.K.B., and Ragaz, J., 1982b, Circulating immune complexes and associated antigen in breast carcinoma, Proc. Am. Assoc. Cancer Res. 23: 250.Google Scholar
  172. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1983a, Detection of epithelial breast carcinoma associated antigen (BCAA) by monoclonal antibodies, Proc. Am. Soc. Clin. Oncol. 2: 103.Google Scholar
  173. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1983b, Immune complexes and human neoplasia: Review II, Biomed. Pharmacother. 37: 211.PubMedGoogle Scholar
  174. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1984, Tumor burden and its relationship to antigen, size and composition of immune complexes, in: Protides of the Biological Fluids ( H.Peeters, ed.), Vol. 31, pp. 749–752, Pergamon Press, Oxford.Google Scholar
  175. Salinas, F.A., Wee, K.H., and Silver, H.K.B., 1985, Clinical relevance of human oncofetal antigen (HOFA) as a marker of tumor burden, in: Protides of the Biological Fluids ( H. Peeters, ed.), Vol. 32, pp. 779–782, Pergamon Press, Oxford.Google Scholar
  176. Scharfstein, J., Correa, E.B., Gallo, G.R., and Nussenzwieg, V., 1979, Human C4-binding protein: Association with immune complexes in-vitro and in-vivo, J. Clin. Invest. 63: 437.PubMedGoogle Scholar
  177. Schupbach, J., Kalyanaraman, V.S., Sarngadharan, M.G., Gunn, P.A., Blayney, D.W., and Gallo, R.C., 1984, Demonstration of viral antigen p24 in circulating immune complexes of two patients with human T-cell leukemia/lymphoma virus (HTLV) positive lymphoma, Lancet 1: 302.PubMedGoogle Scholar
  178. Segal, D.M., and Hurwitz, E., 1977, Binding of affinity cross-linked oligomers of IgG to cells bearing Fc receptors, J. Immunol 118: 1338.PubMedGoogle Scholar
  179. Sela, M., 1969, Antigenicity: Some molecular aspects, Science 166: 1365.PubMedGoogle Scholar
  180. Serrou, B., and Rosenfeld, C. (ed.), 1981, Immune Complexes and Plasma Exchanges in Cancer Patients, Elsevier/North-Holland, Amsterdam.Google Scholar
  181. Siag, W.M., and Jones, J.M., 1982, Alteration by protein A of the distribution of immune complexes containing antigen of retrovirus, Clin. Immunol Immunopathol. 24: 186.PubMedGoogle Scholar
  182. Silver, H.K.B., Karim, K.A., Archibald, E.L., and Salinas, F.A., 1979, Serum sialic acid and sialyltransferase as monitors of tumor burden in malignant melanoma patients, Cancer Res. 39: 5036.PubMedGoogle Scholar
  183. Silver, H.K.B., Karim, K., Gray, M.J., and Salinas, F.A., 1981a, High performance liquid chromatography quantitation of N-acetylneuraminic acid in malignant melanoma and breast carcinoma, J. Chromatogr. (Biomed.Appl.) 224: 381.Google Scholar
  184. Silver, H.K.B., Karim, K., Salinas, F.A., and Swenerton, K.D., 1981b, Significance of sialic acid and carcinoembryonic antigen as monitors of tumor burden among patients with carcinoma of the ovary, J. Surg. Gynecol Obstet. 153: 209.Google Scholar
  185. Silver, H.K.B., Connors, J.M., Karim, K.A., Kong, S., Spinelli, J.J., de Jong, G., McLean, D.M., and Salinas, F.A., 1983, Effect of lymphoblastoid interferon on lymphocyte subsets in cancer patients, J. Biol Resp. Mod. 2: 428.Google Scholar
  186. Silverstein, S.C., Steinman, R.M., and Cohn, Z.A., 1977, Endocytosis, Annu. Rev. Biochem. 46: 669.PubMedGoogle Scholar
  187. Sinclair, StC.N.R., 1979, Modulation of immunity by antibody antigen-antibody complexes and antigen, Pharmacol Ther. 4: 355.Google Scholar
  188. Skogh, T., and Stendahl, O., 1983, Complement-mediated delay in immune complex clearance from the blood owing to reduced deposition outside the reticuloendothelial system, Immunology 49: 53.PubMedGoogle Scholar
  189. Sobel, A.T., Botish, J.A., and Muller-Eberhart, H.J., 1975, C1Q deviation test for the detection of immune complexes, aggregates of IgG and bacterial products in human serum, J. Exp. Med. 142: 130.Google Scholar
  190. Spremulli, E.N., and Dexter, D.L., 1983, Human tumor cell heterogeneity and metastasis, J. Clin. Oncol 1: 496.PubMedGoogle Scholar
  191. Staab, H.J., Anderer, F.A., Stumpf, E., and Fisher, R., 1980, Are CEA immune complexes a prognostic marker in patients with carcinoma at the gastrointestinal tract? Br. J. Cancer 42: 26.PubMedGoogle Scholar
  192. Steele, G., Ankerst, J., and Sjogren, H.O., 1974, Alteration of in vitro activity of tumor bearer sera by adsorption with Staphylococcus aureus Cowan I, Int. J. Cancer 14: 83.PubMedGoogle Scholar
  193. Steward, M.W., and Devey, M.E., 1981, Antigen-antibody complexes: Their nature and role in animal models of antigen-antibody complex disease, in: Immunological Aspects of Rheumatology ( Steward, M.W., and Devey, M.E., ed.), pp. 63–91, Elsevier/North-Holland,.London.Google Scholar
  194. Tan, E.M., and Kunkle, H.G., 1966, An immunofluorescent study of the skin lesions in systemic lupus erythematosus, Arthritis Rheum. 2: 37.Google Scholar
  195. Tanaka, F., Yonemoto, R.H., and Waldman, S.R., 1979, Blocking factors in sera of breast cancer patients, Cancer 43: 838.PubMedGoogle Scholar
  196. Terman, D.S., Yamamoto, T., Mattioli, M., Cook, G., Tillquist, R., Henry, J., Poser, M.R., and Daskal, Y., 1980, Extensive necrosis of spontaneous canine mammary adenocarcinoma after extracorporeal perfusion over Staphylococcus aureus Cowan I, J. Immunol 124: 795.PubMedGoogle Scholar
  197. Terman, D.S., Young, J.B., Shearer, W.T., Ayus, C., Mattioli, C., Lehane, D., Espada, R., Howell, J.F., Yamamoto, T., Zeleski, H.I., Henry, J.F., Feldman, L., Miller, L., Frommer, P., Tillquist, R., Cook, G., and Daskal, Y., 1981, Preliminary observations of the effects on breast carcinoma of plasma perfused over immobilized protein A, N. Engl. J. Med. 305: 1195.PubMedGoogle Scholar
  198. Theofilopoulos, A.N., and Dixon, F.J., 1979, The biology and detection of immune complexes, Adv. Immunol. 28: 89.PubMedGoogle Scholar
  199. Theofilopoulos, A.N., Andrews, B.S., Urist, M.M., Morton, D.L., and Dixon, F.J., 1977, The nature of immune complexes in human cancer sera, J. Immunol. 119: 657.PubMedGoogle Scholar
  200. Theofilopoulos, A.N., Eisenberg, R.A., and Dixon, F.J., 1978, Isolation of circulating immune complexes using Raji cells: Separation of antigen from immune complexes and production of antiserum, J. Clin. Invest. 61: 1570.PubMedGoogle Scholar
  201. Tucker, D.F., Begent, R.H., and Hogg, N.M., 1978, Characterization of immune complexes in serum by absorption on staphylococcal protein A: Model studies and application to sera of rats bearing a Gross virus-induced lymphoma, J. Immunol. 121: 1644.PubMedGoogle Scholar
  202. Unanue, E.R., and Dixon, F.J., 1967, Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens, J. Exp. Med. 125: 149.PubMedGoogle Scholar
  203. Van Es, L.A., Knutson, D.W., Kayser, B.S., and Glassock, R.J., 1979, Soluble oligovalent antigen-antibody complexes. I. The effect of antigen valence and combining ratio on the composition of fluorescein-carrier antifluorescein complexes, Immunology 37: 485.PubMedGoogle Scholar
  204. Virgin, H.W., IV, and Unanue, E.R., 1984, Suppression of the immune response to Listeria monocytogenes. I. Immune complexes inhibit resistance, J. Immunol. 133: 104.PubMedGoogle Scholar
  205. Von Pirquet, C.E., 1911, Allergy, Arch. Intern. Med. 7: 259.Google Scholar
  206. Waller, M., Curry, S., and Richard, A., 1968, Serological specificity of IgG and IgM antiglobulin antibodies in anti-gm (a) antisera, Exp. Immunol. 3: 631.Google Scholar
  207. Ward, P.A., and Cochrane, C.G., 1965, Bound complement and immunologic injury of blood vessels, J. Exp. Med. 121: 215.PubMedGoogle Scholar
  208. Weigle, W.O., 1961, The immune response of rabbits tolerent to bovine serum albumin, J. Exp. Med. 114: 111.PubMedGoogle Scholar
  209. Wreiss, S.J., and Ward, P.A., 1982, Immune complex induced generation of oxygen metabolites by human neutrophils, J. Immunol. 129: 309.Google Scholar
  210. Williams, B.D., Pussel, B.A., Lookwood, C.M., and Cotton, C., 1979, Defective reticuloendothelial system function in rheumatoid arthritis, Lancet 1: 1311.PubMedGoogle Scholar
  211. Williams, R.C., Jr., 1980, Immune Complexes in Clinical and Experimental Medicine, Harvard University Press, Cambridge, Massachusetts.Google Scholar
  212. Wills, E.J., Davies, P., Allison, A.C., and Haswell, A.D., 1972, Cytochalasin B fails to inhibit pinocytosis by macrophages, Nature 240: 58.Google Scholar
  213. Wilson, C.B., and Dixon, F.J., 1981, The renal response to immunological injury, in: The Kidney, 2nd ed. ( M. Bairy, B.M. Brenner, and F.C. Rector, eds.), pp. 1237–1350, Saunders, Philadelphia.Google Scholar
  214. Winchester, R.J., 1983, Foreword, in: Circulating Immune Complexes (L. Espinoza and C. Osterland, eds.), pp. vii–ix, Futura, New York.Google Scholar
  215. World Health Organization, 1977, The role of immune complexes in disease, Technical report series 606, WHO, Geneva.Google Scholar
  216. Zimmerman, S.E., Smith, F.P., Phillips, T.M., Coffey, R.J., and Schein, P.S., 1982, Gastric carcinoma and thrombotic thrombocytopenic purpura: Association with plasma immune complex concentrations, Br. Med. J. 284: 1432.Google Scholar
  217. Zubler, R.H., and Lambert, P.H., 1977, Immune complexes in clinical investigation, in: Recent Advances in Clinical Immunology ( R.A. Thomson, ed.), pp. 125–143, Churchill Livingstone, New York.Google Scholar
  218. Zubler, R.H., Lange, G., Lambert, P.H., and Meischer, P.A., 1976, Detection of immune complexes in unheated sera by modified 125I-Clq binding test: Effect on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus, J. Immunol. 116: 232.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Fernando A. Salinas
    • 1
    • 2
    • 3
  • Kian H. Wee
    • 1
    • 2
    • 3
  • Hulbert K. Silver
    • 1
    • 2
    • 3
  1. 1.Advanced Therapeutics DepartmentCancer Control Agency of British ColumbiaVancouverCanada
  2. 2.Department of PathologyUniversity of British ColumbiaVancouverCanada
  3. 3.Department of MedicineUniversity of British ColumbiaVancouverCanada

Personalised recommendations